Optimization of HIV Care and Treatment

The DC CFAR supports research on the optimization of HIV care and treatment. Active areas of research include engagement and retention in care, barriers to care for highly impacted populations, mechanisms of aging and drug design and delivery.

Active NIH Funding

Palliative Care in People Living with AIDS: Integrating into Standard of Care

4R01NR014052-05
Maureen Lyon, PhD
Children's National Medical Center

Role of PROBDNF and P75NTR in HIV-Mediated Axonal/Dendritic Degeneration

4R01NS079172-05
Italo Mocchetti, PhD
Georgetown University

Washington Women's Interagency HIV/AIDS Study

4U01AI034994-23
Seble Kassaye, MD
Georgetown University

PAR-1 signaling and HAND

4R01NS083410-04
Katherine Conant, MD
Georgetown University

Terry Beirn CPCRA clinical trials unit

5UM1AI069503-10
Virginia (Ginny) Kan, MD
Veterans Affairs Medical Center

DC Cohort

5UM1AI069503-10
Alan Greenberg, MD, MPH
The George Washington University

EVALUATING COMPANION DIAGNOSTICS TO THE ANAL PAP TEST TO IMPROVE PREDICTION OF AIN2+ IN HIV-INFECTED MSM

1R01CA203604-01A1
Jeanne Jordan, PhD
George Washington University

HAART-Mediated Cardiovascular Toxicity in HIV-1 Transgenic Rats: MG Protection

5R21HL125038-02
Ivan Tong Mak, PhD
The George Washington University 

OPIOID WITHDRAWAL AND MICROGLIA: SYNERGISTIC EFFECT WITH HIV-MEDIATED NEURODEGENERATION?

1R21NS102121-01A1
Italo Mocchetti, PhD
Georgetown University

NEF AND NEUROAIDS: ROLE OF CHOLESTEROL METABOLISM IMPAIRMENT AND INFLAMMATION

1R01NS102163-01 
Michael Bukrinsky, MD, PhD
The George Washington University